Nile Pharmaceuticals Shareholders Back Cash and Stock Dividends for Fiscal Year
Nile Pharmaceuticals shareholders approved a 0.50 EGP per share cash dividend for the fiscal year and a EGP 125 million stock dividend, per Reuters.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Shareholders of the Egyptian drugmaker Nile Pharmaceuticals approved a cash dividend for the financial year of 0.50 Egyptian pounds per share.
The meeting also signed off on a share-based payout worth 125 million Egyptian pounds. Reuters reported the decision.
why it matters
The story concerns a small company, so its reach beyond its own investors is limited. For holders of Nile Pharmaceuticals, the vote means a cash payment plus additional shares, and the decision is now settled by shareholder approval.
tags
instruments
sources
- Nile Pharmaceuticals Shareholders Approve FY Dividend — Reuters, 1 November 2026 at 08:59 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗